Works by Para, Michael F.


Results: 16
    1
    2
    3

    A Pooled Analysis of Eight Clinical Studies Suggests a Link Between Influenza-Like Symptoms and Pharmacodynamics of the Toll-Like Receptor-7 Agonist Vesatolimod.

    Published in:
    Infectious Diseases & Therapy, 2024, v. 13, n. 11, p. 2285, doi. 10.1007/s40121-024-01034-w
    By:
    • Riddler, Sharon A.;
    • Benson, Constance A.;
    • Brinson, Cynthia;
    • Deeks, Steven G.;
    • DeJesus, Edwin;
    • Mills, Anthony;
    • Para, Michael F.;
    • Ramgopal, Moti N.;
    • Cai, Yanhui;
    • Zheng, Yanan;
    • Zhang, Liao;
    • Jiang, Wendy;
    • Liu, Xiaopeng;
    • Verrill, Donovan;
    • Lim, Daina;
    • de Vries, Christiaan R.;
    • Wallin, Jeffrey J.;
    • Vendrame, Elena;
    • SenGupta, Devi
    Publication type:
    Article
    4

    Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257.

    Published in:
    Clinical Infectious Diseases, 2016, v. 62, n. 12, p. 1842, doi. 10.1093/cid/civ193
    By:
    • Ofotokun, Ighovwerha;
    • Na, Lumine H.;
    • Landovitz, Raphael J.;
    • Ribaudo, Heather J.;
    • McComsey, Grace A.;
    • Godfrey, Catherine;
    • Aweeka, Francesca;
    • Cohn, Susan E.;
    • Sagar, Manish;
    • Kuritzkes, Daniel R.;
    • Brown, Todd T.;
    • Patterson, Kristine B.;
    • Para, Michael F.;
    • Leavitt, Randi Y.;
    • Villasis-Keever, Angelina;
    • Baugh, Bryan P.;
    • Lennox, Jeffrey L.;
    • Currier, Judith S.
    Publication type:
    Article
    5

    Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257.

    Published in:
    Clinical Infectious Diseases, 2015, v. 60, n. 12, p. 1842, doi. 10.1093/cid/civ193
    By:
    • Ofotokun, Ighovwerha;
    • Na, Lumine H.;
    • Landovitz, Raphael J.;
    • Ribaudo, Heather J.;
    • McComsey, Grace A.;
    • Godfrey, Catherine;
    • Aweeka, Francesca;
    • Cohn, Susan E.;
    • Sagar, Manish;
    • Kuritzkes, Daniel R.;
    • Brown, Todd T.;
    • Patterson, Kristine B.;
    • Para, Michael F.;
    • Leavitt, Randi Y.;
    • Villasis-Keever, Angelina;
    • Baugh, Bryan P.;
    • Lennox, Jeffrey L.;
    • Currier, Judith S.
    Publication type:
    Article
    6

    The Safety and Efficacy of Zidovudine (AZT) in the Treatment of Subjects with Mildly Symptomatic Human Immunodeficiency Virus Type 1 (HIV) Infection.

    Published in:
    Annals of Internal Medicine, 1990, v. 112, n. 10, p. 727, doi. 10.7326/0003-4819-112-10-727
    By:
    • Fisehl, Margaret A.;
    • Richman, Douglas D.;
    • Hansen, Nellie;
    • Collier, Ann C.;
    • Carey, John T.;
    • Para, Michael F.;
    • Hardy, W. David;
    • Dolin, Raphael;
    • Powderly, William G.;
    • Allan, J. Davis;
    • Wong, Brian;
    • Merigan, Thomas C.;
    • McAuliffe, Vincent J.;
    • Hyslop, Newton F.;
    • Rhame, Frank S.;
    • Balfour, Henry H.;
    • Spector, Stephen A.;
    • Volberding, Paul;
    • Pettinelli, Carla
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16